Microbiological monitoring of ventilator-associated pneumonia in an intensive care unit;Mikrobiologisches Monitoring bei Ventilator-assoziierten Pneumonien auf Intensivstationen

Deutsche Medizinische Wochenschrift

Volumn 135, Issue 5, 2010, Pages 197-202

  Joost, I ^a   Lange, C ^b   Seifert, H ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

Author keywords

Microbiological monitoring; Surveillance cultures; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

BACTERIUM CULTURE; CLINICAL STUDY; HEALTH SURVEY; HOSPITAL INFECTION; INTENSIVE CARE UNIT; MICROBIOLOGICAL EXAMINATION; MONITORING; MORTALITY; RESPIRATORY TRACT INFECTION; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA; BACTERIAL COUNT; CROSS INFECTION; EVIDENCE BASED MEDICINE; HUMAN; LUNG LAVAGE; MICROBIOLOGY; MULTIDRUG RESISTANCE; PRACTICE GUIDELINE;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; BRONCHOALVEOLAR LAVAGE FLUID; COLONY COUNT, MICROBIAL; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EVIDENCE-BASED MEDICINE; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; PRACTICE GUIDELINES AS TOPIC;

EID: 77249141202     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0029-1244836     Document Type: Review

References (34)

1. ACourt C H., Garrard C S., Crook D, et al. Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. Q J Med 1993 86 635-648
2. American Thoracic Society (ATS). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005 171 388-416
3. Bagshaw S M., Laupland K B. Epidemiology of intensive care unit-acquired urinary tract infections. Curr Opin Infect Dis 2006 19 67-71
4. Bouza E, Perez A, Munoz P, et al. Ventilator-associated pneumonia after heart surgery: a prospective analysis and the value of surveillance. Crit Care Med 2003 31 1964-1970
5. Chastre J, Fagon J Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002 165 867-903
6. Delclaux C, Roupie E, Blot F, Brochard L, Lemaire F, Brun-Buisson C. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis. Am J Respir Crit Care Med 1997 156 1092-1098
7. Dennesen P J., van der Veen A J., Kessels A G., Ramsay G, Bonten M J. Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001 163 1371-1375
8. Depuydt P, Benoit D, Vogelaers D, et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008 34 675-682
9. Dupont H, Mentec H, Sollet J P., Bleichner G. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001 27 355-362
10. Frere P, Hermanne J P., Debouge M H., de Moc P, Fillet G, Beguin Y. Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplant 2004 33 745-749
11. George D L., Falk P S., Wunderink R G., et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J Respir Crit Care Med 1998 158 1839-1847
12. Hayon J, Figliolini C, Combes A, et al. Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia. Am J Respir Crit Care Med 2002 165 41-46
13. Hyllienmark P, Gardlund B, Persson J O., Ekdahl K. Nosocomial pneumonia in the ICU: a prospective cohort study. Scand J Infect Dis 2007 39 676-682
14. Iregui M, Ward S, Sherman G, Fraser V J., Kollef M H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002 122 262-268
15. Jarvis W R. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996 17 552-557
16. Jung B, Sebbane M, Chanques G, et al. Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia. Intensive Care Med 2008 35 101-107
17. Reinhart K, Brunkhorst FM, Bone H G., et al. Diagnose und Therapie der Sepsis. Der Internist 2006 47 356-373
18. Kollef M H., Sherman G, Ward S, Fraser V J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999 115 462-474
19. Lorenz J, Bodmann K F., Bauer T T., Ewig S, Trautmann M, Vogel F. [Nosocomial pneumonia: prevention, diagnosis, treatment]. Pneumologie 2003 57 532-545 (Pubitemid 37211210)
20. Luna C M., Vujacich P, Niederman M S., et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997 111 676-685
21. Masterton R G., Galloway A, French G, et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008 62 5-34
22. Michel F, Franceschini B, Berger P, et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 2005 127 589-597
23. Nationales Referenzzentrum für die Surveillance von nosokomialen Infektionen (NRZ). Modul ITS KISS Referenzdaten. 2009
24. Pugin J, Auckenthaler R, Mili N, Janssens J P., Lew P D., Suter P M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic blind bronchoalveolar lavage fluid. Am Rev Respir Dis 1991 143 1121-1129
25. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993 104 1230-1235
26. Sanders K M., Adhikari N K., Friedrich J O., Day A, Jiang X, Heyland D. Previous cultures are not clinically useful for guiding empiric antibiotics in suspected ventilator-associated pneumonia: secondary analysis from a randomized trial. J Crit Care 2008 23 58-63
27. Sintchenko V, Iredell J R., Gilbert G L. Antibiotic therapy of ventilator-associated pneumonia-a reappraisal of rationale in the era of bacterial resistance. Int J Antimicrob Agents 2001 18 223-229
28. Strassburg A, Rupp J, Herth F J., Magnussen H, Zabel P, Lange C. [Infection diagnostics in pneumology. Part 1. Survey and methods]. Pneumologie 2008 62 730-743
29. Tablan O C., Anderson L J., Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004 53 1-36
30. Torres A, Ewig S, Lode H, Carlet J. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2008 35 9-29
31. Trouillet J L., Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998 157 531-539
32. Valles J, Artigas A, Rello J, et al. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995 122 179-186
33. Valles J, Pobo A, Garcia-Esquirol O, Mariscal D, Real J, Fernandez R. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset. Intensive Care Med 2007 33 1363-1368
34. Zuschneid I, Geffers C, Sohr D, et al. Validation of surveillance in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol 2007 28 496-499 (Pubitemid 46658068)